Statewide

Ministry of Health, Emergency Health Regulatory and Accountability Branch

Name: Ministry of Health, Emergency Health Regulatory and Accountability Branch EMS protocol doses
Creator: ProtoQuiz
License: https://protoquiz.com/census/data-license/

Current90 dose entries32 drugs1 documentOntario, Canadaeffective 2025-06-02100% machine-parsed of 90

Drugs and doses32

A–C Acetaminophen, Adenosine, Amiodarone, Atropine, Buprenorphine-Naloxone, Calcium Gluconate6

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	960–1000 mg	PO	not captured	standing	pages 217, 264
Other	adult	960–1000 mg	PO	not captured	standing	pages 219, 266
Mild to moderate pain	adult	960–1000 mg	PO	not captured	standing	pages 81, 176
Mild to moderate pain	peds	500–650 mg	PO	not captured	standing	pages 81, 176

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	6 mg	IV	not captured	standing	page 147

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	300 mg	IV/IO	not captured	standing	page 117
Other	peds	5 mg/kg	IV/IO	not captured	standing	page 117

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV	not captured	standing	page 143
Nerve agent exposure	adult	2 mg	IM	not captured	standing	pages 234, 281
Nerve agent exposure	peds	0.5 mg	IM	not captured	standing	pages 234, 281

Buprenorphine-Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	16 mg	SL	not captured	standing	pages 74, 168

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	page 151

D–F Dexamethasone, Dextrose, Diazepam, Dimenhydrinate, Diphenhydramine, Dopamine, Epinephrine, Fentanyl8

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Croup	adult	0.5 mg/kg	PO	not captured	standing	pages 43, 105
Croup	peds	0.5 mg/kg	PO	not captured	standing	pages 43, 105
Other	adult	0.5 mg/kg	IV/IM/PO	not captured	standing	pages 38, 100
Other	peds	0.5 mg/kg	IV/IM/PO	not captured	standing	pages 38, 100

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	0.5 g/kg	IV	not captured	standing	pages 69, 160
Hypoglycemia	peds	0.2 g/kg	IV	not captured	standing	pages 69, 160

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	10 mg	IM	not captured	standing	pages 230, 235, 277, 282
Nerve agent exposure	peds	0.2 mg/kg	IM	not captured	standing	pages 230, 235, 277, 282

Dimenhydrinate

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	50 mg	IV/IM	not captured	standing	pages 84, 183
Nausea / vomiting	peds	25 mg	IV/IM	not captured	standing	pages 84, 183

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	50 mg	IV/IM	not captured	standing	pages 41, 103
Other	adult	50 mg	PO	not captured	standing	pages 215, 262
Other	peds	25 mg	IV/IM	not captured	standing	pages 41, 103

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	5 mcg/kg	IV	not captured	standing	page 143
Cardiogenic shock	adult	5 mcg/kg	IV	not captured	standing	page 140
Post-ROSC care	adult	5 mcg/kg	IV	not captured	standing	page 131

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	0.01 mg/kg	IM	not captured	standing	pages 51, 116
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	page 116
Cardiac arrest	adult	2 mg	ET	not captured	standing	page 116
Cardiac arrest	peds	0.01 mg/kg	IM	not captured	standing	pages 51, 116
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	page 116
Neonatal resuscitation	peds	0.01 mg/kg	IV/IO	not captured	standing	page 126
Other	peds	0.01 mg/kg	IM	not captured	standing	pages 38, 100
Other	peds	0.01 mg/kg	IM	not captured	standing	pages 41, 103

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	25–75 mcg	IV/IN	not captured	standing	page 177
Mild to moderate pain	peds	1 mcg/kg	IV/IN	not captured	standing	page 177
Procedural sedation	adult	25–75 mcg	IV/IO/IN	not captured	standing	page 252

G–L Glucagon, Hydrocortisone, Hydroxocobalamin, Ibuprofen, Ketamine, Ketorolac, Lidocaine7

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	1 mg	IM	not captured	standing	pages 70, 161
Hypoglycemia	adult	3 mg	IN	not captured	standing	pages 70, 161
Hypoglycemia	peds	0.5 mg	IM	not captured	standing	pages 70, 161

Hydrocortisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 mg/kg	IV/IM/PO	not captured	standing	pages 38, 78, 100, 172
Other	peds	2 mg/kg	IV/IM/PO	not captured	standing	pages 38, 78, 100, 172

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV	not captured	standing	pages 222, 269
Cyanide poisoning	peds	70 mg/kg	IV	not captured	standing	pages 222, 269

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	400 mg	PO	not captured	standing	pages 82, 176

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg/kg	IM	not captured	standing	page 180
Mild to moderate pain	adult	0.25 mg/kg	IV	not captured	standing	page 178
Mild to moderate pain	peds	0.25 mg/kg	IV	not captured	standing	page 178

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	10–15 mg	IV/IM	not captured	standing	pages 82, 176

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1.5 mg/kg	IV/IO	not captured	standing	page 117
Other	adult	3 mg/kg	ET	not captured	standing	page 117
Other	peds	1 mg/kg	IV/IO	not captured	standing	page 117

M–O Midazolam, Morphine, Naloxone, Nitroglycerin, Ondansetron, Oxytocin6

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	0.1 mg/kg	IV/IM/IN	not captured	standing	page 180
Nerve agent exposure	adult	10 mg	IM	not captured	standing	pages 230, 235, 277, 282
Nerve agent exposure	peds	0.2 mg/kg	IM	not captured	standing	pages 230, 235, 277, 282
Procedural sedation	adult	0.1 mg/kg	IV/IO/IN	not captured	standing	page 252
Seizure	adult	0.1 mg/kg	IV/IO	not captured	standing	page 165
Seizure	adult	0.2 mg/kg	IM/IN/BUC	not captured	standing	page 165
Seizure	peds	0.1 mg/kg	IV/IO	not captured	standing	page 165
Seizure	peds	0.2 mg/kg	IM/IN/BUC	not captured	standing	page 165

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 mg	IV	not captured	standing	page 135
Mild to moderate pain	adult	2–10 mg	IV/SQ	not captured	standing	page 177
Mild to moderate pain	peds	0.05–0.1 mg/kg	IV/SQ	not captured	standing	page 177

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.4 mg	IM	not captured	standing	pages 74, 168
Opioid overdose	adult	0.8 mg	SQ	not captured	standing	pages 74, 168
Opioid overdose	adult	2–4 mg	IN	not captured	standing	pages 74, 168
Opioid overdose	adult	0.4 mg	IV/IO	not captured	standing	pages 74, 168
Opioid overdose	peds	0.4 mg	IM	not captured	standing	pages 74, 168
Opioid overdose	peds	0.8 mg	SQ	not captured	standing	pages 74, 168
Opioid overdose	peds	2–4 mg	IN	not captured	standing	pages 74, 168
Opioid overdose	peds	0.4 mg	IV/IO	not captured	standing	pages 74, 168

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	0.3 mg	SL	not captured	standing	pages 67, 137
Other	adult	0.3 mg	SL	not captured	standing	pages 65, 135

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/IM/PO	not captured	standing	pages 84, 183

Oxytocin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10 unit	IM	not captured	standing	pages 90, 189

P–R Pralidoxime1

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	600 mg	IM	not captured	standing	pages 229, 234, 276, 281
Nerve agent exposure	peds	15 mg/kg	IM	not captured	standing	pages 229, 234, 276, 281

S–Z Salbutamol, Sodium Thiosulfate, Tranexamic Acid, Xylometazoline4

Salbutamol

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1600 mcg	MDI	not captured	standing	page 152
Hyperkalemia	adult	10 mg	NEB	not captured	standing	page 152
Other	adult	5 mg	NEB	not captured	standing	pages 38, 100
Other	adult	800 mcg	MDI	not captured	standing	pages 38, 100
Other	peds	2.5 mg	NEB	not captured	standing	pages 38, 100
Other	peds	600 mcg	MDI	not captured	standing	pages 38, 100

Sodium Thiosulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	12.5 g	IV	not captured	standing	pages 221, 268
Cyanide poisoning	peds	400 mg/kg	IV	not captured	standing	pages 221, 268

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Trauma / hemorrhage	adult	1000 mg	IV	not captured	standing	pages 197, 248
Trauma / hemorrhage	adult	1000 mg	IM	not captured	standing	pages 197, 248

Xylometazoline

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	2 spray	TOP	not captured	standing	page 241

Cite this

Ministry of Health, Emergency Health Regulatory and Accountability Branch, United States EMS Protocol Census. 90 dose entries, effective 2025-06-02.

https://protoquiz.com/census/agencies/ministry-of-health-emergency-health-regulatory-and-accountability-branch/

Outdated or wrong? Fix or remove it All Ontario, Canada agencies Methodology Data license Study these protocols in the app

The census is free and not for sale. Only public agencies are named.